Christopher Heery, CHIEF MEDICAL OFFICER at Arcellx, Inc. (ACLX), sold 53,702 shares at $67.24 ($3.6M) on 2024-09-03, disclosed to the SEC on 2024-09-03.
Scheduled sale ($3.6M) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.05 | 14,776 | $976K | 27.1% |
| 2 | $66.05 | 14,776 | $976K | 27.1% |
| 3 | $67.24 | 6,617 | $445K | 12.4% |
| 4 | $67.24 | 6,617 | $445K | 12.4% |
| 5 | $68.01 | 1,958 | $133K | 3.7% |
| 6 | $68.01 | 1,958 |
| $133K |
| 3.7% |
| 7 | $69.06 | 1,200 | $83K | 2.3% |
| 8 | $70.07 | 2,900 | $203K | 5.6% |
| 9 | $70.07 | 2,900 | $203K | 5.6% |
| Total | $66.99 avg | 53,702 | $3.6M | 100% |
| Filing → |
| ACLX | SELL | 2026-01-12 | $393K | — | Filing → |
| ACLX | SELL | 2025-11-17 | $31K | — | Filing → |
| ACLX | SELL | 2025-09-30 | $2.9M | — | Filing → |